Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail

Publikation: Bog/antologi/afhandling/rapportPh.d.-afhandlingForskning

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@phdthesis{d33c4501ac084c59afb96e19c40a6d73,
title = "Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail",
author = "Mark Hvistendahl",
year = "2019",
language = "English",
publisher = "Faculty of Health Sciences, University of Copenhagen",

}

RIS

TY - BOOK

T1 - Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail

AU - Hvistendahl, Mark

PY - 2019

Y1 - 2019

M3 - Ph.D. thesis

BT - Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail

PB - Faculty of Health Sciences, University of Copenhagen

ER -

ID: 59435161